vs

Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.

PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $61.6M, roughly 1.2× BEYOND MEAT, INC.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs -19.7%). PUMA BIOTECHNOLOGY, INC. produced more free cash flow last quarter ($14.4M vs $-49.8M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs -9.7%).

Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.

Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.

BYND vs PBYI — Head-to-Head

Bigger by revenue
PBYI
PBYI
1.2× larger
PBYI
$75.5M
$61.6M
BYND
Growing faster (revenue YoY)
PBYI
PBYI
+47.4% gap
PBYI
27.7%
-19.7%
BYND
More free cash flow
PBYI
PBYI
$64.2M more FCF
PBYI
$14.4M
$-49.8M
BYND
Faster 2-yr revenue CAGR
PBYI
PBYI
Annualised
PBYI
31.3%
-9.7%
BYND

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BYND
BYND
PBYI
PBYI
Revenue
$61.6M
$75.5M
Net Profit
Gross Margin
-11.5%
69.3%
Operating Margin
-211.4%
22.7%
Net Margin
Revenue YoY
-19.7%
27.7%
Net Profit YoY
EPS (diluted)
$0.68
$0.26

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BYND
BYND
PBYI
PBYI
Q4 25
$61.6M
$75.5M
Q3 25
$70.2M
$54.5M
Q2 25
$75.0M
$52.4M
Q1 25
$68.7M
$46.0M
Q4 24
$76.7M
$59.1M
Q3 24
$81.0M
$80.5M
Q2 24
$93.2M
$47.1M
Q1 24
$75.6M
$43.8M
Net Profit
BYND
BYND
PBYI
PBYI
Q4 25
Q3 25
$-110.7M
$8.8M
Q2 25
$-29.2M
$5.9M
Q1 25
$-52.9M
$3.0M
Q4 24
Q3 24
$-26.6M
$20.3M
Q2 24
$-34.5M
$-4.5M
Q1 24
$-54.4M
$-4.8M
Gross Margin
BYND
BYND
PBYI
PBYI
Q4 25
-11.5%
69.3%
Q3 25
10.3%
77.7%
Q2 25
11.5%
76.5%
Q1 25
-1.5%
77.1%
Q4 24
13.1%
76.4%
Q3 24
17.7%
63.9%
Q2 24
14.7%
77.4%
Q1 24
4.9%
75.5%
Operating Margin
BYND
BYND
PBYI
PBYI
Q4 25
-211.4%
22.7%
Q3 25
-160.0%
17.6%
Q2 25
-46.6%
12.7%
Q1 25
-81.8%
8.7%
Q4 24
-49.3%
22.6%
Q3 24
-38.2%
27.4%
Q2 24
-36.4%
-4.6%
Q1 24
-70.7%
-5.3%
Net Margin
BYND
BYND
PBYI
PBYI
Q4 25
Q3 25
-157.6%
16.2%
Q2 25
-39.0%
11.2%
Q1 25
-77.0%
6.5%
Q4 24
Q3 24
-32.8%
25.2%
Q2 24
-37.0%
-9.6%
Q1 24
-71.9%
-11.0%
EPS (diluted)
BYND
BYND
PBYI
PBYI
Q4 25
$0.68
$0.26
Q3 25
$-1.44
$0.17
Q2 25
$-0.38
$0.12
Q1 25
$-0.69
$0.06
Q4 24
$-0.65
$0.40
Q3 24
$-0.41
$0.41
Q2 24
$-0.53
$-0.09
Q1 24
$-0.84
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BYND
BYND
PBYI
PBYI
Cash + ST InvestmentsLiquidity on hand
$203.9M
$97.5M
Total DebtLower is stronger
$415.7M
$22.7M
Stockholders' EquityBook value
$-997.0K
$130.3M
Total Assets
$614.7M
$216.3M
Debt / EquityLower = less leverage
0.17×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BYND
BYND
PBYI
PBYI
Q4 25
$203.9M
$97.5M
Q3 25
$117.3M
$94.4M
Q2 25
$103.5M
$96.0M
Q1 25
$102.1M
$93.2M
Q4 24
$131.9M
$101.0M
Q3 24
$121.7M
$96.7M
Q2 24
$144.9M
$96.8M
Q1 24
$157.9M
$107.2M
Total Debt
BYND
BYND
PBYI
PBYI
Q4 25
$415.7M
$22.7M
Q3 25
$1.2B
$34.0M
Q2 25
$1.2B
$45.3M
Q1 25
$1.1B
$56.7M
Q4 24
$1.1B
$68.0M
Q3 24
$1.1B
$79.3M
Q2 24
$1.1B
$90.7M
Q1 24
$1.1B
$102.0M
Stockholders' Equity
BYND
BYND
PBYI
PBYI
Q4 25
$-997.0K
$130.3M
Q3 25
$-784.1M
$115.3M
Q2 25
$-677.0M
$104.7M
Q1 25
$-649.5M
$97.1M
Q4 24
$-601.2M
$92.1M
Q3 24
$-611.9M
$71.1M
Q2 24
$-590.0M
$48.5M
Q1 24
$-561.4M
$51.0M
Total Assets
BYND
BYND
PBYI
PBYI
Q4 25
$614.7M
$216.3M
Q3 25
$599.7M
$202.9M
Q2 25
$691.7M
$194.9M
Q1 25
$643.8M
$196.2M
Q4 24
$678.1M
$213.3M
Q3 24
$692.9M
$220.7M
Q2 24
$711.2M
$205.0M
Q1 24
$735.0M
$214.1M
Debt / Equity
BYND
BYND
PBYI
PBYI
Q4 25
0.17×
Q3 25
0.30×
Q2 25
0.43×
Q1 25
0.58×
Q4 24
0.74×
Q3 24
1.12×
Q2 24
1.87×
Q1 24
2.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BYND
BYND
PBYI
PBYI
Operating Cash FlowLast quarter
$-46.8M
$14.4M
Free Cash FlowOCF − Capex
$-49.8M
$14.4M
FCF MarginFCF / Revenue
-80.8%
19.1%
Capex IntensityCapex / Revenue
4.8%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-157.2M
$41.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BYND
BYND
PBYI
PBYI
Q4 25
$-46.8M
$14.4M
Q3 25
$-38.8M
$9.7M
Q2 25
$-33.2M
$14.1M
Q1 25
$-26.1M
$3.6M
Q4 24
$-29.0M
$15.6M
Q3 24
$-22.0M
$11.0M
Q2 24
$-16.0M
$1.0M
Q1 24
$-31.8M
$11.2M
Free Cash Flow
BYND
BYND
PBYI
PBYI
Q4 25
$-49.8M
$14.4M
Q3 25
$-41.7M
$9.7M
Q2 25
$-35.1M
$14.1M
Q1 25
$-30.6M
$3.6M
Q4 24
$-35.4M
$15.6M
Q3 24
$-24.1M
$11.0M
Q2 24
$-17.3M
$1.0M
Q1 24
$-33.0M
FCF Margin
BYND
BYND
PBYI
PBYI
Q4 25
-80.8%
19.1%
Q3 25
-59.4%
17.7%
Q2 25
-46.9%
26.8%
Q1 25
-44.6%
7.7%
Q4 24
-46.2%
26.4%
Q3 24
-29.7%
13.7%
Q2 24
-18.6%
2.1%
Q1 24
-43.7%
Capex Intensity
BYND
BYND
PBYI
PBYI
Q4 25
4.8%
0.0%
Q3 25
4.1%
0.0%
Q2 25
2.6%
0.0%
Q1 25
6.5%
0.1%
Q4 24
8.4%
0.0%
Q3 24
2.5%
0.0%
Q2 24
1.4%
0.0%
Q1 24
1.6%
0.0%
Cash Conversion
BYND
BYND
PBYI
PBYI
Q4 25
Q3 25
1.10×
Q2 25
2.41×
Q1 25
1.21×
Q4 24
Q3 24
0.54×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons